en
Scientific article
English

Plasma treatment for improving cell biocompatibility of a biodegradable polymer scaffold for vascular graft applications

Published inEuropean journal of pharmaceutics and biopharmaceutics, vol. 85, no. 1, p. 78-86
Publication date2013
Abstract

Biodegradable synthetic scaffolds are being evaluated by many groups for the application of vascular tissue engineering. In addition to the choice of the material and the structure of the scaffold, tailoring the surface properties can have an important effect on promoting adequate tissue regeneration. The objective of this study was to evaluate the effect of an increased hydrophilicity of a polycaprolactone vascular graft by treatment with a cold air plasma. To this end, treated and untreated scaffolds were characterized, evaluated in vitro with smooth muscle cells, and implanted in vivo in the rat model for 3weeks, both in the subcutaneous location and as an aortic replacement. The plasma treatment significantly increased the hydrophilicity of the scaffold, with complete wetting after a treatment of 60sec, but did not change fiber morphology or mechanical properties. Smooth muscle cells cultured on plasma treated patches adopt a spread out morphology compared to a small, rounded morphology on untreated patches. Subcutaneous implantation revealed a low foreign body reaction for both types of scaffolds and a more extended and dense cellular infiltrate in the plasma treated scaffolds. In the vascular position, the plasma treatment induced a better cellularization of the graft wall, while it did not affect endothelialization rate or intimal hyperplasia. Plasma treatment is therefore an accessible tool to easily increase the biocompatibility of a scaffold and accelerate tissue regeneration without compromising mechanical strength, which are valuable advantages for vascular tissue engineering.

Citation (ISO format)
VALENCE, Sarra de et al. Plasma treatment for improving cell biocompatibility of a biodegradable polymer scaffold for vascular graft applications. In: European journal of pharmaceutics and biopharmaceutics, 2013, vol. 85, n° 1, p. 78–86. doi: 10.1016/j.ejpb.2013.06.012
Main files (1)
Article (Accepted version)
accessLevelRestricted
Identifiers
ISSN of the journal0939-6411
613views
2downloads

Technical informations

Creation08/29/2013 8:23:00 AM
First validation08/29/2013 8:23:00 AM
Update time03/14/2023 8:24:14 PM
Status update03/14/2023 8:24:14 PM
Last indexation01/16/2024 2:07:30 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack